Cargando…
Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
Advancements in medicine have increased the longevity of humans, resulting in a higher incidence of chronic diseases. Due to the rise in the elderly population, age-dependent neurodegenerative disorders are becoming increasingly prevalent. The available treatment options only provide symptomatic rel...
Autores principales: | Chaudhary, Sapana, Chaudhary, Sameer, Rawat, Sakshi, Kulkarni, Archana, Bilgrami, Anwar L., Perveen, Asma, Alghamdi, Badrah S., Zughaibi, Torki Al, Ashraf, Ghulam Md, Alam, Mohammad Zubair, Hussain, Tabish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569834/ https://www.ncbi.nlm.nih.gov/pubmed/36232314 http://dx.doi.org/10.3390/ijms231911012 |
Ejemplares similares
-
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
por: Rahman, Md. Mominur, et al.
Publicado: (2023) -
Involvement of Phytochemical-Encapsulated Nanoparticles’ Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours
por: Mehan, Sidharth, et al.
Publicado: (2022) -
Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis
por: Sayed, Ahmed, et al.
Publicado: (2022) -
Studies on the role of goat heart galectin-1 as an erythrocyte membrane perturbing agent
por: Ashraf, Ghulam Md, et al.
Publicado: (2014) -
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
por: Almikhlafi, Mohannad A., et al.
Publicado: (2023)